arsenic has been researched along with T-Cell Lymphoma in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (50.00) | 29.6817 |
2010's | 1 (50.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Bhalla, S; Crombie, J; Evens, AM; Gartenhaus, RB; Kandela, I; Mazar, A; Ravi, D; Sharma, J | 1 |
Bu, Q; Cai, QQ; Gao, Y; Huang, HQ; Li, S; Liao, H; Zhou, Y | 1 |
2 other study(ies) available for arsenic and T-Cell Lymphoma
Article | Year |
---|---|
The novel organic arsenical darinaparsin induces MAPK-mediated and SHP1-dependent cell death in T-cell lymphoma and Hodgkin lymphoma cells and human xenograft models.
Topics: Animals; Apoptosis; Arsenic; Arsenicals; Cell Cycle; Cell Death; Cell Line, Tumor; Cell Survival; Disease Models, Animal; Extracellular Signal-Regulated MAP Kinases; Glutathione; Hodgkin Disease; Humans; Intracellular Space; Lymphoma, T-Cell; Mice; Mitogen-Activated Protein Kinases; Protein Tyrosine Phosphatase, Non-Receptor Type 6; Signal Transduction; Tumor Burden; Xenograft Model Antitumor Assays | 2014 |
Effects of arsenic trioxide under different administration ways on T-cell lymphoma xenografts in nude mice: in vivo and in vitro experiments.
Topics: Animals; Apoptosis; Arsenic Trioxide; Arsenicals; Cell Line, Tumor; Cell Nucleus; Cell Proliferation; Cell Survival; Dose-Response Relationship, Drug; Female; Flow Cytometry; Inhibitory Concentration 50; Lymphoma, T-Cell; Male; Mice; Mice, Nude; Microscopy, Electron; Microscopy, Fluorescence; Neoplasms, Experimental; Oxides; Time Factors; Tumor Burden | 2009 |